WayPoint Biomedical WYPH Stock
WayPoint Biomedical Price Chart
WayPoint Biomedical WYPH Financial and Trading Overview
| WayPoint Biomedical stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0002 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0001 - 0.07 USD |
| Volume | 1.01K USD |
| Avg. Volume | 22.25K USD |
| Market Cap | 7.48K USD |
| Beta (5Y Monthly) | 64.925 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.022 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
WYPH Valuation Measures
| Enterprise Value | 496.4K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.22503686 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 14.934 |
| Enterprise Value/EBITDA | -0.524 |
Trading Information
WayPoint Biomedical Stock Price History
| Beta (5Y Monthly) | 64.925 |
| 52-Week Change | -99.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000188 USD |
| 200-Day Moving Average | 0.01 USD |
WYPH Share Statistics
| Avg. Volume (3 month) | 22.25K USD |
| Avg. Daily Volume (10-Days) | 111.15K USD |
| Shares Outstanding | 37.42M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2005 |
| Most Recent Quarter (mrq) | June 30, 2006 |
| Next Fiscal Year End | December 31, 2006 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2854.55% |
| Gross Margin | -46.24% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 33.24K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | -52.80% |
| Gross Profit (ttm) | -28964 USD |
| EBITDA | -947026 USD |
| Net Income Avi to Common (ttm) | -806273 USD |
| Diluted EPS (ttm) | -0.022 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.47K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 495.13K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.056 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of WayPoint Biomedical
| Country | United States |
| State | CA |
| City | Huntington Beach |
| Address | 17011 Beach Boulevard |
| ZIP | 92647 |
| Phone | 714-848-3200 |
| Website | N/A |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | N/A |
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Q&A For WayPoint Biomedical Stock
What is a current WYPH stock price?
WayPoint Biomedical WYPH stock price today per share is 0.0001 USD.
How to purchase WayPoint Biomedical stock?
You can buy WYPH shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for WayPoint Biomedical?
The stock symbol or ticker of WayPoint Biomedical is WYPH.
Which industry does the WayPoint Biomedical company belong to?
The WayPoint Biomedical industry is Shell Companies.
How many shares does WayPoint Biomedical have in circulation?
The max supply of WayPoint Biomedical shares is 18.37M.
What is WayPoint Biomedical Price to Earnings Ratio (PE Ratio)?
WayPoint Biomedical PE Ratio is now.
What was WayPoint Biomedical earnings per share over the trailing 12 months (TTM)?
WayPoint Biomedical EPS is -0.022 USD over the trailing 12 months.
Which sector does the WayPoint Biomedical company belong to?
The WayPoint Biomedical sector is Financial Services.